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Abstract
Background: Clinical symptoms of rheumatoid arthritis (RA) improve in the course of the day, as can synovitis
activity, reported via doppler ultrasound (US). The aim of the study was to establish whether the Color Doppler (CD)
scores of synovitis in RA changes throughout the day.
Methods: In total, 27 patients with active RA, including 14 patients receiving corticosteroids were studied. US
evaluation was performed twice in each patient, at 9 a.m. (T0) and after 4 p.m. (T1) on the same day by a single
radiologist and using the same instrument. Overall, 30 joints were assessed, including grey scale and CD (S0 = no
flow [no detectable CD)]; S1 =mild [CD <1/3 of the synovium]; S2 =moderate [CD <2/3]; S3 = pronounced [CD >2/3]).
Results: In the total population, synovitis was detected more often in the evening than in the morning (39% vs. 33%,
p = 0.02). The difference remained significant only in patients without corticosteroid administration (44% vs. 37%, p = 0.
04). Moreover, a greater number of CD-positive joints were likewise found (S0 vs. S1 + S2 + S3) in the evening (57% vs.
51%, p = 0.04) in patients not receiving corticosteroids (67% vs. 41%, p = 0.002). More moderate (S2) and pronounced
(S3) than mild (S1) synovitis was observed at T1 vs. T0 (39% vs. 24%, p = 0.03) in patients not receiving corticosteroids.
More synovitis (40% vs 36% p = 0.02) in the dominant hand were found in the evening than in the morning.
Conclusion: Synovitis and CD activity increase during the day in RA patients, especially in joints of the dominant
hands and in patients without corticosteroids.
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Background
Rheumatoid arthritis (RA) is a chronic, destructive, in-
flammatory disease of the synovium. The initial symptoms
of synovitis include pain and swelling of the affected
joints, with stiffness predominantly in the morning. Poor
outcome, which may develop at an earlier or later point in
the disease progression, is accounted for by the develop-
ment of bone erosions with joint destruction, possibly
leading to severe long-term disabilities.
There is evidence that ultrasound (US) displays greater
sensitivity than clinical examination in detecting synovitis
[1, 2]. US assessment of synovitis includes grey scale (GS;
a measurement of synovial thickness or hypertrophy) and
color Doppler (CD) or power Doppler (PD; a measure-
ment of synovial vascularity, that may better reflect active
inflammation). PD activity has also been shown to be
the best predictor of subsequent damage in the affected
joint in DMARD-treated patients in remission [2].
Ultrasonography of MCPJs is an early, reliable indicator
of therapeutic response in RA [3]. Clinical RA symp-
toms were found to be more severe in the morning,
while improving throughout the day. Laboratory find-
ings revealed a circadian rhythm for synthesis of pro-
inflammatory markers, including cytokines and inter-
leukin (IL-6) [4]. These findings suggest that synovitis
activity varies in the course of the day, which may be
detected by Doppler US [5]. The aim of this study was
to confirm the results obtained by Seremano et al., who
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showed a reduction in MCP synovitis activity in 10 pa-
tients suffering from active RA but, unlike this group,
by examining the MCP, PIP and MTP joints.
Methods
Patients
Overall, 27 patients were enrolled in the study. All pa-
tients met the 1987 American College of Rheumatology
(ACR) criteria for RA [6] with active disease defined as
disease activity score based on 28 joints–erythrocyte
sedimentation rate (DAS28–ESR) greater than 2.6. The
entire population underwent US examination in both
the morning and evening in conjunction with clinical
and laboratory assessments (ESR and CRP, only per-
formed in the morning). This study is interventional and
patients were informed of their right, and provided their
consent to take part. Ethical approval was obtained from
the local ethics committee (CPP Sud-Est VI, 21/11/
2012), and the project was submitted to the Commission
Nationale de l’Informatique et des Libertés (CNIL).
Clinical assessment
Demographic data, clinical features and RA treatments
were recorded. The clinical examination investigating
the painful swollen joints and thus allowing DAS28 to
be calculated was only performed in the morning, as it
seemed unlikely that clinical synovitis would vary be-
tween morning and evening. The DAS was recorded by
experienced rheumatologists blinded to the US assess-
ment. CRP and ESR were measured in order to assess
disease activity using the DAS28-ESR and DAS28-CRP.
Ultrasonography
Ultrasound was performed twice in each patient, at
9 a.m. (T0) and after 4 p.m. (T1) on the same day by a
single experienced radiologist and using the same
instrument (ANTARES, SIEMENS, 2004 or IU 22, PHI-
LIPS, 2010 using a 5–13 MHz and a 5–12-MHz linear
array transducer respectively). No stand-off pad was
employed. The radiologist was blinded to the clinical
findings. Overall, 30 joints were scanned from the dor-
sal aspect, using the long axis : bilateral wrist (distal
radioulnar joint, radio- and mediocarpal joint), bilateral
hand (second to fifth metacarpophalangeal (MCP)
joints and proximal interphalangeal (PIP) joints and bi-
lateral forefoot (dorsal recess of the second to fifth
MTP). The US assessment of synovitis included grey
scale and color Doppler measurements. Color Doppler
mode was applied to minimize examination time. Syno-
vitis on grey-scale measurements was defined via syn-
ovial hypertrophy, although no scoring was performed
[7]. Synovial vascularization was visualized on color
Doppler and scored semi-quantitatively from 0 to 3 (S0
= inactive synovitis [no detectable Doppler signal inside
the joint]; S1 = mild [Doppler signal involving <1/3 of
the synovium]; S2 = moderate [Doppler signal involving
>1/3 but < 2/3 of the synovium]; and S3 = pronounced
[>2/3 of the synovium involved]) [8, 9]. Still images
from all the examinations were stored on local PACS
(Picture archive and communication system). The
examination room temperature was recorded before
each US.
Intra-observer agreement was calculated by reviewing
static stored images of the second to fifth MCP and the
second to fifth PIP and wrists in ten patients, in color
Doppler mode with a second reading taken 3 months
later.
Statistical analysis
Statistical analysis was performed using Stata software
(version 12; Stata-Corp, College Station, Tex., USA). Con-
tinuous data were presented as mean ± standard deviation
(SD) values. A statistical analysis was performed in order
to assess the concordance between RA synovitis measure-
ments taken in the morning and in the afternoon on both
grey scale and CD. To reflect variability between different
joints in the same patient, intra-subject correlations were
corrected assuming an a priori correlation structure for
correlated measurements. The primary analysis was
conducted using the marginal logistic model with esti-
mation of the generalized estimating equation (GEE).
The Wald test with robust variance estimate was
employed for inference. The kappa coefficient was used
to measure the radiologist’s agreement (intra-observer
reliability). A p-value of <0.05 (two-tailed) was consid-
ered statistically significant.
Results
Overall, 23 women and 4 men with a mean age 64.3 ±
12.4 years affected by RA present for 12.9 ± 12.3 years
were included in the study. The examination was per-
formed on 17 inpatients and 10 outpatients.
Rheumatoid factor (RF) and anti-cyclic citrullinated
protein (anti-CCP) antibodies were positive in 51.8% of
cases, with erosive RA present in 55.5% of cases. In
total, 16 patients were receiving methotrexate at a
mean dose of 12.8 ± 2.3 mg, three leflunomide, two
sulfasalazine and five hydroxychloroquine. Overall, 16
patients were receiving biological therapy (abatacept:
six patients; rituximab: five patients; etanercept: four
patients; golimumab: the remainig one patient). In
addition, 14 patients were on corticosteroid therapy at
a mean dose of 7.8 ± 4.3 mg. The RA was active with a
DAS28-ESR of 4.7 ± 1.3 and DAS28-CRP of 4.3 ± 1.2.
All patients taking steroid administered their treat-
ment in the morning, around 2 h before the US scan
was performed. A total of 486 joints were co-
investigated clinically and by US. More joints affected by
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synovitis were detected by US [225/486 (46.2%)] than by
clinical assessments [129/486 (27%)].
In the total study population, synovitis was detected
more often in the evening than in the morning (N vs.
S0123), with synovitis found in 39% of cases in the
evening but only in 33% in the morning (p = 0.02)
(Table 1). This difference remained significant in pa-
tients not being administered corticosteroid tretment
(44% vs. 37%, p = 0.04) but was not in patients under
corticosteroids (34% vs. 30%, p = 0.20). The increase in
Table 1 Comparison of cumulated CD synovitis and normal synovium in all patients, in those with corticosteroids (WC), and in
those without (WhC) at T0 and T1
N compared to CD synovitis (S0123)
Total T0 (% of joints) Total T1 (% of joints) p
WC WhC WC WhC WC WhC
Both sides Wrist 48 49 0.77
48 49 48 51 1 0.64
MCP 46 55 0.02
41 51 48 63 0.20 0.06
PIP 20 28 0.03
16 24 22 34 0.18 0.08
MTP 24 26 0.41
20 28 21 30 0.62 0.51
All joints 33 39 0.02
30 37 34 44 0.20 0.04
Right side Wrist 46 47 0.83
43 49 43 51 1 0.71
MCP 48 58 0.07
43 54 50 67 0.34 0.10
PIP 19 32 0.01
18 21 29 37 0.07 0.06
MTP 20 25 0.27
16 25 20 31 0.54 0.35
All joints 33 40 0.02
29 36 35 46 0.19 0.04
Left side Wrist 51 52 0.81
52 49 52 51 1 0.75
MCP 44 52 0.11
39 48 46 58 0.28 0.23
PIP 20 23 0.55
14 27 16 31 0.78 0.56
MTP 27 26 0.96
23 31 23 30 1 0.94
All joints 34 38 0.33
31 38 33 42 0.59 0.40
p-values are based on marginal models estimated by GEE and considering an adjustment on corticosteroid therapy (yes/no)
p-values in bold type indicates < 0.05
p-values in italic type indicates between 0.05 and 0.10
WC: patients with corticosteroid therapy (n = 14)
WhC: patients without corticosteroid therapy (n = 13)
T0: before 9 am; T1: at 4 pm
N: normal synovium
S0: inactive synovitis: no detectable Doppler signal inside the joint
S1: mild synovitis: Doppler signal involving <1/3 of the synovium
S2: moderate synovitis: Doppler signal involving >1/3 but <2/3 of the synovium
S3: pronounced synovitis: Doppler signal involving >2/3 of the synovium
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synovitis was significant for the MCP (55% vs. 46%, p =
0.02) and PIP joints (28 vs. 21%, p = 0.03) when consid-
ering both hands but remained significant for PIP only
on the dominant hand (32% vs 19%), p = 0.01), when
each side was oserved separately.
There was more active synovitis (S123) than inactive
synovitis (S0) in the evening than in the morning (57%
vs. 51%, p = 0.04), though this difference proved only sig-
nificant in patients not receiving corticosteroids (67% vs.
41%, p = 0.002) (Table 2). The difference was observed in
Table 2 Comparison of synovitis without doppler signal (S0) and with Doppler signal (S1 + S2 + S3) in all patients, in those with
corticosteroids (WC), and in those without (WhC), at T0 and T1
CD synovitis S0 compared to S123
Total T0 (% of joints) Total T1 (% of joints) p
WC WhC WC WhC WC WhC
Both sides Wrist 54 58 0.37
50 58 50 65 0.98 0.21
MCP 57 66 0.08
43 68 46 82 0.55 0.06
PIP 47 60 0.02
72 28 52 66 0.49 0.001
MTP 38 35 0.83
45 32 29 40 0.19 0.41
All joints 51 57 0.04
50 51 45 67 0.59 0.002
Right side Wrist 49 50 0.55
39 58 39 60 0.43 0.75
MCP 52 65 0.10
33 68 43 83 0.41 0.12
PIP 57 60 0.37
80 36 50 68 0.27 0.05
MTP 54 33 0.10
67 46 27 38 0.06 0.77
All joints 52 55 0.46
47 56 41 67 0.51 0.12
Left side Wrist 59 64 0.33
59 58 59 70 0.98 0.21
MCP 62 66 0.41
55 68 50 80 0.93 0.26
PIP 37 60 0.07
62 21 56 62 0.84 0.02
MTP 25 37 0.30
31 20 31 43 1 0.19
All joints 49 59 0.04
52 47 50 68 0.97 0.01
p-values are based on marginal models estimated by GEE and considering an adjustment on corticosteroid therapy (yes/no)
p-values in bold type indicates < 0.05
p-values in italic type indicates between 0.05 and 0.10
WC: patients with corticosteroid therapy (n = 14)
WhC: patients without corticosteroid therapy (n = 13)
T0: before 9 am; T1: at 4 pm
S0: inactive synovitis: no detectable Doppler signal inside the joint
S1: mild synovitis: Doppler signal involving <1/3 of the synovium
S2: moderate synovitis: Doppler signal involving >1/3 but <2/3 of the synovium
S3: pronounced synovitis: Doppler signal involving >2/3 of the synovium
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the PIP of both hands, though only in patients not re-
ceiving corticosteroids (68% vs. 36%, p = 0.05).
The level of active synovitis (S1 vs. S23) was greater in
the evening than in the morning in patients not receiv-
ing corticosteroids when considering all joints in both
hands (38% vs. 24%, p = 0.03) (Table 3), all joints of the
dominant hand (41% vs. 28%, p = 0.04) or the MCP of
the dominant hand (59% vs. 33%, p = 0.01).
Subgroup analysis on patients with/without methotrexte
(MTX) and with/without biotherapy were performed,
showing no statistical differences between morning and
evening assessment of synovitis (N vs S0S1S2S3), CD-
Table 3 Comparison of mild CD synovitis (S1) and moderate to pronounced CD synovitis (S2 + S3) in all patients, in patients with
corticosteroids (WC), and in those without (WhC), at T0 and T1
CD synovitis S1 compared to S23
Total T0 (% of joints) Total T0 (% of joints) p
WC WhC WC WhC WC WhC
Both sides Wrist 12 17 0.44
15 9 20 15 0.56 0.49
MCP 39 54 0.07
45 36 44 45 0.99 0.03
PIP 50 48 0.85
62 29 62 62 0.96 0.33
MTP 26 11 0.31
40 11 14 40 0.35 0.98
All joints 31 39 0.10
38 24 37 38 0.93 0.03
Right side Wrist 11 16 0.68
29 0 29 8 0.97 0.98
MCP 33 59 0.01
25 37 42 66 0.25 0.02
PIP 33 43 0.22
50 0 63 31 0.48 0.52
MTP 33 11 0.26
50 17 0 17 0.32 0.89
All joints 28 41 0.04
38 20 40 42 0.56 0.03
Left side Wrist 13 19 0.59
18 15 21 18 0.53 0.95
MCP 45 49 0.61
35 46 50 35 0.51 0.28
PIP 75 53 0.35
67 60 50 67 0.44 0.68
MTP 14 10 0.97
0 25 0 0 0. 80 1
All joints 34 36 0.76
29 34 37 29 0.77 0.50
p-values are based on marginal models estimated by GEE and considering an adjustment on corticosteroid therapy (yes/no)
p-values in bold type indicates < 0.05
WC: patients with corticosteroid therapy (n = 14)
WhC: patients without corticosteroid therapy (n = 13)
T0: before 9 am; T1: at 4 pm
S1: mild synovitis: Doppler signal involving <1/3 of the synovium
S2: moderate synovitis: Doppler signal involving >1/3 but <2/3 of the synovium
S3: pronounced synovitis: Doppler signal involving >2/3 of the synovium
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positive synovitis (S0 vs. S123) or pronounced synovitis
(S1 vs. S23).
The examination room was 23.8 ± 0.7°C in the morn-
ing and 25.4 ± 0.9 in the evening. Intra-observer reliabil-
ity values were 0.94 to 1 for MCP joints and 0.86 to 1
for PIP joints.
Discussion
Our study shows that the number and activity of joints
affected by synovitis increase throughout the day. More
joints affected by synovitis were found in the evening
than in the morning. The same has applies to synovitis
activity but in patients not receiving corticosteroids. In
these patients, more active synovitis was observed in the
evening than in the morning in the PIP of the dominant
hand, with higher intensity for the PIP and MCP.
Conversely, a report by Semerano et al. [5] reported
on a diurnal variation in the PDUS signal from MCP
joints in 10 patients with active RA, which was higher in
the morning than in the afternoon or evening, along
with the disappearance of Doppler activity from some
joints in the evening. The authors suggested that this
variation appears to mirror the circadian variation in the
joint stiffness and pain wharacterizing RA.
Semerano et al., however, studied only MCP joints in
the morning, the joints in which we found least variation
in synovitis activity, apart from the increase in grade 2
and 3 right-hand MCP synovitis. Additional studies are
thus required to explain these inconsistent results. Th
observed difference could also be explained by the ad-
ministration of corticosteroids, which were shown to re-
duce the variation in synovitis intensity in our study.
The administration of corticosteroids was not detailed in
the study by Semerano, in which the first echography
was carried out between 7 a.m. and 10 a.m. In our study,
patients had taken their medication proior to undergo-
ing echography.
Several elements that might explain our results can
be considered. The first is the fact that US is operator-
dependent, although this does not appear to be the
explanation, as the investigation was performed by an
experienced radiologist, reproducible results.
The room temperature was higher in the evening
than in the morning, which may have potentially af-
fected the results. Some authors have reported a de-
crease in Doppler signal after cooling the skin [10, 11].
Ellegaard et al., however, showed that heat did not
affect Doppler synovitis activity [11]. This explanation
is thus rather unlikely. Further explorations are re-
quired in oreder to better understand why synovitis is
found more often in the evening than in the morning.
The larger number and greater activity of synovitis
joints in the dominant hand may suggest that physical
activity plays a role. That said, a study invilving 29 RA
patients showed no significant changes in the wrist Dop-
pler signal after 8 weeks of exercise, though the MCP
and PIP joints were not studied in this work [12].
US is an increasingly used tool in the management of
RA patients. In agreement with results reported in the
literature, US allowed for detecting more inflamed
joints than clinical examination in our study [13]. Nu-
merous studies have shown that PD activity of synovitis
to be a predictive factor for radiological progression
and relapse in patients in remission with low disease
activity [14, 15].
Moreover, US was often able to detect acute synovitis in
patients considered to be in clinical remission [16–18].
The US examination, however, was only performed in the
dominant hand in these studies which was shown to vary
most over the day according to our results [17, 18].
Conclusions
Our results suggest the relevance of considering the time
at which studies are initiated when assessing the utility
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